EverPoint Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

EverPoint Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-780,000	Closed	-$18.7M	–	539
2016 Q2	$18.7M	Buy	+780,000	New	+$17.9M	0.37%	76
2015 Q4	–	Sell	-100,000	Closed	-$3.97M	–	563
2015 Q3	$3.97M	Sell	100,000 -155,000	-61%	-$9.62M	0.1%	249
2015 Q2	$17.6M	Sell	255,000 -200,000	-44%	-$12.6M	0.32%	84
2015 Q1	$24.9M	Buy	455,000 +380,000	+507%	+$18.1M	0.47%	57
2014 Q4	$3.2M	Buy	+75,000	New	+$2.71M	0.07%	310

Other funds holding AMAG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EverPoint Asset Management's AMAG Position: Q3 2016 in Review

EverPoint Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2016, closing a stake of 780,000 shares — an estimated $18.7M sold.

EverPoint Asset Management first reported a position in AMAG in Q4 2014 and held it in 5 quarters. The position peaked at $24.9M in Q1 2015. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

EverPoint Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
EverPoint Asset Management sold 780,000 AMAG Pharmaceuticals shares in Q3 2016, an estimated $18.7M.
EverPoint Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 5 quarters.
EverPoint Asset Management's AMAG Pharmaceuticals position peaked at $24.9M in Q1 2015.
178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on EverPoint Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.